Government think tank NITI Aayog's members along with top medical experts have requested the people eligible for vaccination not to fall for rumours on safety. They added that minor adverse effects are common and should not deter people from inoculation

Norway COVID-19 immunisation: The Norwegian Institute of Public Health has cautioned against vaccinating elderly people above 80 years of age saying those with a short life span may not benefit much from the jab

Pfizer must conduct local study for vaccine approval: VK Paul Any vaccine maker, including Pfizer, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local \"bridging\" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters. Serum Institute of India, the local manufacturer of the vaccine developed by AstraZeneca and Oxford University, has done a similar study on more than 1...

Around 3 lakh frontline healthcare workers will be inoculated at 2,934 sites across the country on the first day of January 16, according to Health Ministry

As of now, the pre-condition for any vaccine to be implemented in India is that you have to do a bridging trial, said Niti Aayog member VK Paul who also heads National Expert Group On Vaccine Administration for COVID-19 (NEGVAC)

Coronavirus vaccine dry run in Delhi: Union Health Minister Harsh Vardhan visited Delhi's Guru Teg Bahadur hospital to review dry run of coronavirus vaccine today

The new strain of COVID-19 in the United Kingdom has increased transmissibility. This mutation is not affecting the severity of the disease. Case fatality is not affected by this mutation, said Dr VK Paul, Member (Health), NITI Aayog

Constitution of committees and their responsibilities are in sync with broad instructions issued by Centre; decision to provide vaccine for free was conveyed by Chief Minister Pinarayi Vijayan at a presser on Saturday

MSMEs are the backbone of economy; it contributes 30 per cent to India's GDP, 48 per cent in export and till now, 11 crore jobs have been created by MSME sector, says Gadkari

VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system

COVID-19 vaccine trial updates: AIIMS director Dr Randeep Guleria has pinned his hopes on the five coronavirus vaccine candidates which are in varying stages of trials across India

However, VK Paul, who heads the National Task Force on COVID-19, had said in November that the arrival of the Pfizer vaccine in India might take months.

Coronavirus in Delhi: The High Court has asked the government to file a status report explaining the steps taken to control the spread of COVID-19

India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients

IMD Director General Mrutyunjay Mohapatra said that the prevailing weak La Nina conditions in the Pacific Ocean are likely to influence and trigger severe cold conditions across the country

Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months

Coronavirus update: The Health Ministry said that five states have the maximum caseload in the country -- Maharashtra, Karnataka, Kerala, Andhra Pradesh and Tamil Nadu

COVID-19 impact: Large companies maintaining digital transformation budgets, says TCSA significant number of large enterprises have either maintained their digital transformation budget or increased it even as the COVID-19 pandemic as impacted revenue of businesses globally, according to a survey by Tata Consultancy Services (TCS). Prior to the pandemic, the average organisation surveyed had only 9 per cent of its workforce working mostly from home. That percentage has increased seven-fold a...

Although, experts have observed that seasonal changes have had little effect on the spread of coronavirus. In the case of winters, experts have appealed for additional precautions

Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies